文献速递眼底病与葡萄膜炎神经眼科

无临床可检出视网膜病变的糖尿病患者早期视网膜神经血管损害

Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy.
PubMed 文献 · Br J Ophthalmol · 2019-01-23

本研究纳入66例无视网膜病变的2型糖尿病患者与62名健康对照,采用无散瞳全视野闪烁ERG和OCTA评估视网膜功能与神经血管结构。结果显示患者组黄斑区SCP与DCP血管密度、视盘周围RNFL厚度及RPC密度均降低,闪烁ERG潜伏期延迟、振幅下降,且潜伏期延迟与HbA1c升高及黄斑旁SCP血管密度降低相关,而与GCC厚度无关。

要点

  • 无可见视网膜病变的糖尿病患者已存在视网膜功能与微血管结构损害。
  • 闪烁ERG潜伏期延迟与HbA1c升高及黄斑旁SCP血管密度降低相关。
  • 早期功能改变可能与微血管异常而非神经节细胞丢失相关。

核心结论

  • 糖尿病患者在无可见视网膜病变时已出现功能与结构损害。
  • 早期功能改变可能与细微微血管异常而非神经节细胞丢失相关。
  • 血糖控制不佳与临床前糖尿病视网膜病变的闪烁ERG潜伏期延迟相关。

研究设计与样本

  • 纳入66例无视网膜病变的2型糖尿病患者(NDR)与62名健康对照。
  • 采用无散瞳全视野闪烁ERG设备(RETeval)行16与32 Tds闪烁ERG检查。
  • 采用OCTA定量黄斑区SCP与DCP血管密度、FD300及GCC厚度。
  • 采用OCTA测量视盘周围RNFL厚度与RPC密度。

主要发现

  • NDR组黄斑旁与黄斑周围SCP和DCP血管密度均较对照组降低(均p<0.01)。
  • 两组黄斑GCC厚度无显著差异(p=0.661)。
  • NDR组视盘周围RNFL厚度与RPC密度显著低于对照组(分别为p<0.001与p=0.009)。
  • NDR组闪烁ERG潜伏期延迟、振幅下降(均p<0.01)。
  • 16与32 Tds潜伏期延迟与HbA1c升高(β=0.350,p<0.001;β=0.328,p<0.001)及黄斑旁SCP血管密度降低(β=-0.266,p=0.013;β=-0.253,p=0.005)相关,与GCC厚度无关(β=-0.008,p=0.818)。

临床怎么用

  • 对无临床可见视网膜病变的糖尿病患者可考虑闪烁ERG与OCTA评估早期神经血管改变。
  • 关注HbA1c控制与黄斑旁SCP血管密度,其与闪烁ERG潜伏期延迟相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To investigate the function and the corresponding neurovascular structures in patients with diabetes without clinically detectable retinopathy. METHODS : Sixty-six patients with type 2 diabetes without retinopathy (NDR) and 62 healthy controls were recruited. The 16 and 32 Tds flicker electroretinography (ERG) was performed using a mydriasis-free, full-field flicker ERG recording device (RETeval). The vessel density (VD) of superficial capillary plexus (SCP) and deep capillary plexus (DCP), FD300 and ganglion cell complex (GCC) thickness in the macula were quantified using optical coherence tomography angiography (OCTA). The retinal nerve fibre layer (RNFL) thickness and the radial peripapillary capillary (RPC) density in the peripapillary area were also measured with OCTA. RESULTS: Parafoveal and perifoveal VD in both SCP and DCP decreased in NDR group in comparison to control group (all p<0.01). However, macular GCC thickness was comparable between the two groups (p=0.661). Peripapillary RNFL thickness and RPC density were significantly lower in NDR group (p<0.001 and p=0.009, respectively). With regard to ERG parameters, delayed implicit time and decreased amplitude were found in NDR group in comparison to the control group (all p<0.01). In the multiple linear regression analyses, delayed implicit time for 16 and 32 Tds stimuli was significantly correlated with increased HbA1c (β=0.350, p<0.001; β=0.328, p<0.001, respectively) and decreased VD of SCP in the parafoveal region (β=-0.266, p=0.013; β=-0.253, p=0.005, respectively). However, delayed implicit time for 16 and 32 Tds stimuli was not correlated with the thickness of GCC (β=-0.008, p=0.818) in multiple linear regression analyses. CONCLUSION: Functional and structural impairments have already started in diabetic retina even in the absence of visible retinal lesions. Subtle microvascular abnormalities rather than ganglion cell loss might be associated with early functional changes in NDR patients. Poor control of blood glucose was associated with delayed implicit time of flicker ERG in preclinical diabetic retinopathy.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Zeng Y, Cao D, Yu H, et al. Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy. Br J Ophthalmol. 2019. PMID: 30674454. doi:10.1136/bjophthalmol-2018-313582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。